Nerivio®
Theranica Secures $45 Million Series C Funding Round
Theranica advises the proceeds will fund the U.S. commercial expansion of migraine treatment device , Nerivio®
- Go to the previous page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- …
- 90
- Go to the next page